相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype
Teresa Cejalvo et al.
CANCERS (2020)
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G. Richardson et al.
ONCOIMMUNOLOGY (2020)
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study
Jin-Huan Wei et al.
LANCET ONCOLOGY (2019)
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar et al.
VIRCHOWS ARCHIV (2019)
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu-Chao Zhang et al.
NATURE COMMUNICATIONS (2019)
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P. Barthel et al.
NATURE (2019)
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G. Kerr et al.
JOURNAL OF IMMUNOLOGY (2019)
Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas
Hao Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Molecular subtyping of tumors from patients with familial glioma
Vanessa Y. Ruiz et al.
NEURO-ONCOLOGY (2018)
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups
Chris Lauber et al.
BMC CANCER (2018)
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis
Ryohei Otani et al.
CANCER SCIENCE (2018)
Targeting tumour microenvironment by tyrosine kinase inhibitor
Hor-Yue Tan et al.
MOLECULAR CANCER (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens et al.
EUROPEAN JOURNAL OF CANCER (2017)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
Xin Hu et al.
NEURO-ONCOLOGY (2017)
Correlation of immune phenotype with IDH mutation in diffuse glioma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2017)
Glioma Subclassifications and Their Clinical Significance
Ricky Chen et al.
NEUROTHERAPEUTICS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
Zheng Zhao et al.
SCIENTIFIC DATA (2017)
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer
Thomas Karn et al.
JAMA ONCOLOGY (2017)
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Aleix Prat et al.
CANCER RESEARCH (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H. Baumeister et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion
Tomohiro Kawaguchi et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
Xiaoran Zhang et al.
NEURO-ONCOLOGY (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping
Yinyan Wang et al.
NEURO-ONCOLOGY (2015)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis et al.
BRAIN PATHOLOGY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Predicting survival from microarray data -: a comparative study
H. M. Bovelstad et al.
BIOINFORMATICS (2007)
分享论文
